News

ANEUVO's Innovative ExaStim® Therapy Revolutionizes SCI Care

ANEUVO's Innovative ExaStim® Therapy Revolutionizes SCI Care

ANEUVO's Participation at Major SCI Rehabilitation Events

ANEUVO is set to make waves in the field of spinal cord injury (SCI) rehabilitation as it showcases its cutting-edge technology, ExaStim® Therapy, at two prominent international conferences. These events, renowned for uniting experts and innovators in SCI care, are providing ANEUVO a platform to highlight its revolutionary therapy designed to enhance the quality of life for individuals with spinal cord injuries.

Highlighting ExaStim® Therapy

ExaStim® Therapy is recognized as the first and only non-invasive transcutaneous spinal stimulation system approved in Europe aimed at improving upper extremity motor function in adults with SCI. This innovative development marks a significant milestone in the rehabilitation community, offering new hope to those affected by spinal cord injuries.

RehaCare 2025 – Düsseldorf, Germany

At RehaCare 2025, scheduled from September 17 to 20, in Düsseldorf, ANEUVO will present at Booth Hall 6, Stand F66. This renowned trade fair attracts healthcare professionals dedicated to transforming patient care, providing a perfect venue for showcasing advancements in rehabilitation technology.

Visitors to the ANEUVO booth can explore the outstanding features of ExaStim® Therapy, which include a 16-channel multi-electrode array and customizable settings designed to meet individual patient needs. Attendees will gain insights on how this portable and precise system can be seamlessly incorporated into various rehabilitation settings - from hospitals to home care.

Insights from ISCoS 2025 – Gothenburg, Sweden

Following RehaCare, ANEUVO is poised to participate in the International Spinal Cord Society’s 64th Annual Scientific Meeting (ISCoS 2025) from October 8 to 11 in Gothenburg, where the company will shine a light on pioneering advancements in neuromodulation. The event will feature a Lunch Symposium on October 10, where initial results from the ASPIRE™ study, a significant multi-center trial on ExaStim® Therapy conducted on adults with chronic, traumatic SCI, will be unveiled.

The ASPIRE™ Home Study is another focus at ISCoS, exploring the potential for at-home rehabilitation supported by telehealth. As the company continues to refine its technologies, it aims to provide critical support that enhances independence and normalcy in daily activities for individuals living with SCI.

Transforming Lives with ExaStim® Therapy

ExaStim® Therapy is designed to be a game-changer in the context of spinal rehabilitation. By providing non-invasive stimulation without the risks associated with surgical interventions, ANEUVO leads with an innovative solution that can be utilized in diverse healthcare environments. The rechargeable device applies targeted stimulation through a flexible pad equipped with 16 electrodes, promoting mobility restoration and improved strength.

This technology is available for patients experiencing acute, sub-acute, or chronic spinal injuries, offering them renewed hope and improved functional independence.

Features and Benefits of ExaStim® Therapy

Among its many advantages, ExaStim® Therapy is equipped with:

  • Customizable stimulation settings that adapt to individual muscle responses.
  • An intuitive app-based interface facilitating ease of use for clinicians and caregivers.
  • Extensive reporting tools for tracking patient progress effectively.

These features make it an appealing option for integrating into rehabilitation programs across different settings.

Continued Commitment to Innovation

ANEUVO is at the forefront of advancing bioelectronic medicine, with ongoing clinical studies highlighting the potential of ExaStim® Therapy. The recently completed ASPIRE™ Study and the ongoing ASPIRE™ Home Study reflect the company’s dedication to expanding knowledge and improving outcomes for patients facing the challenges of SCI.

Additionally, the anticipated European commercial launch of ExaStim® Therapy heralds a new chapter in the accessibility of groundbreaking treatment options for those in need.

Frequently Asked Questions

What is ExaStim® Therapy?

ExaStim® Therapy is a non-invasive spinal stimulation system designed to enhance upper extremity motor function in adults with spinal cord injuries.

Where will ANEUVO showcase its technology?

ANEUVO will present ExaStim® Therapy at the RehaCare event in Düsseldorf and the ISCoS meeting in Gothenburg.

What are the key features of ExaStim® Therapy?

This therapy system includes customizable stimulation settings, a user-friendly app interface, and a flexible design for effective patient treatment.

What types of patients can benefit from ExaStim® Therapy?

Adults experiencing acute, sub-acute, or chronic spinal injuries are eligible to benefit from this therapy.

How does ANEUVO contribute to SCI rehabilitation?

ANEUVO focuses on developing innovative solutions, improving the quality of life for individuals affected by spinal cord injuries through advanced therapeutic methods.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Webull Faces Class Action: Key Details for Investors

Updated Category News Views 219

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 270

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 238

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 247

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 158

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 271

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 139

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 177

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 249

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 127

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading

Top 5 Most Recently Viewed Articles

Flexible Office Market Set to Surge with Hybrid Work Dynamics

Updated Category News Views 271

The Rise of the Flexible Office Market The global flexible office market is positioned for significant growth, expected to expand by USD 28.32 billion during the forecast period from 2024 to 2028. This optimistic outlook is driven by evolving work patterns, particularly the transition towards remote and hybrid working environments. Market Dynamics Fuelling Growth A key...

Continue Reading
Slick City Action Park's Expansion: 50 Locations and Growing

Updated Category News Views 606

Slick City Action Park Celebrates Major Growth with 50 Locations Slick City Action Park, celebrated as the world’s first indoor slide and air court park for people of all ages, is marking a remarkable growth milestone: it now has 50 locations that are either operational or in the signing phase. This milestone highlights the rapid expansion of their brand, which has...

Continue Reading
Autodesk Inc's Bright Future: Growth Trends and Insights

Updated Category News Views 146

Is Autodesk Prepared for a Breakout Year? Autodesk Inc (NASDAQ: ADSK) is positioned to achieve remarkable growth, particularly as we look toward the upcoming quarters. With the company's strategic emphasis on cloud technology and artificial intelligence, along with its impressive financial results, the forecast for Autodesk appears exceedingly promising. The company has...

Continue Reading
OptimumBank Holdings Reports Impressive Q3 2024 Earnings

Updated Category News Views 144

Strong Financial Results for OptimumBank Holdings, Inc. OptimumBank Holdings, Inc. (NASDAQ: OPHC) recently announced its financial performance for the third quarter, revealing significant growth and profitability. The company's net income reached $3.3 million, translating to $0.34 per basic share and $0.32 per diluted share. This is a noteworthy increase compared to $1.2...

Continue Reading
AESC Expands Leadership with New Regional Council Members

Updated Category News Views 417

AESC Expands Leadership with New Regional Council Members The Association of Executive Search and Leadership Consultants (AESC) has welcomed 14 new members to its Regional Councils, strengthening its mission of representing the global executive search and leadership consulting sector. About AESC AESC represents a $20+ billion industry with a network of over 1,200 offices...

Continue Reading